Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Krüppel-like factor 4 prevents centrosome amplification following γ-irradiation-induced DNA damage

Abstract

Centrosome duplication is a carefully controlled process in the cell cycle. Previous studies indicate that the tumor suppressor, p53, regulates centrosome duplication. Here, we present evidence for the involvement of the mammalian Krüppel-like transcription factor, KLF4, in preventing centrosome amplification following DNA damage caused by γ-irradiation. The colon cancer cell line HCT116, which contains wild-type p53 alleles (HCT116 p53+/+), displayed stable centrosome numbers following γ-irradiation. In contrast, HCT116 cells null for the p53 alleles (HCT116 p53−/−) exhibited centrosome amplification after irradiation. In the latter cell line, KLF4 was not activated following γ-irradiation due to the absence of p53. However, centrosome amplification could be suppressed in irradiated HCT116 p53−/− cells by conditional induction of exogenous KLF4. Conversely, in a HCT116 p53+/+ cell line stably transfected with small hairpin RNA (shRNA) designed to specifically inhibit KLF4, γ-irradiation induced centrosome amplification. In these cells, the inability of KLF4 to become activated in response to DNA damage was directly associated with an increase in cyclin E level and Cdk2 activity, both essential for regulating centrosome duplication. Cotransfection experiments showed that KLF4 overexpression suppressed the promoter activity of the cyclin E gene. The results of this study demonstrated that KLF4 is both necessary and sufficient in preventing centrosome amplification following γ-radiation-induced DNA damage and does so by transcriptionally suppressing cyclin E expression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Abbreviations

BSA:

bovine serum albumin

Cdk2:

cyclin-dependent kinase 2

DPBS:

Dulbecco's phosphate-buffered saline

FBS:

fetal bovine serum

GKLF:

gut-enriched Krüppel-like factor

KLF4:

Krüppel-like factor 4

MEFs:

mouse embryonic fibroblasts

PBS:

phosphate-buffered saline

shRNA:

small hairpin RNA

References

  • Al-Romaih K, Bayani J, Vorobyova J, Karaskova J, Park PC, Zielenska M and Squire JA . (2003). Cancer Genet. Cytogenet., 144, 91–99.

  • Bennett RA, Izumi H and Fukasawa K . (2004). Oncogene, 23, 6823–6829.

  • Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Eilers M, Hatzigeorgiou A and Jansen-Durr P . (1996). Mol. Cell. Biol., 16, 3401–3409.

  • Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B . (1998). Science, 282, 1497–1501.

  • Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B and Lengauer C . (2002). Cancer Res., 62, 1129–1133.

  • Carder P, Wyllie AH, Purdie CA, Morris RG, White S, Piris J and Bird CC . (1993). Oncogene, 8, 1397–1401.

  • Carroll PE, Okuda M, Horn HF, Biddinger P, Stambrook PJ, Gleich LL, Li YQ, Tarapore P and Fukasawa K . (1999). Oncogene, 18, 1935–1944.

  • Chen X, Johns DC, Geiman DE, Marban E, Dang DT, Hamlin G, Sun R and Yang VW . (2001). J. Biol. Chem., 276, 30423–30428.

  • Dang DT, Mahatan CS, Dang LH, Agboola IA and Yang VW . (2001). Oncogene, 20, 4884–4890.

  • Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, Pinkel D, Gray J, Bradley A, Medina D and Varmus HE . (1996). Prog. Clin. Biol. Res., 395, 1–11.

  • Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP and Munger K . (2000). Proc. Natl. Acad. Sci. USA, 97, 10002–10007.

  • Ekholm SV, Zickert P, Reed SI and Zetterberg A . (2001). Mol. Cell. Biol., 21, 3256–3265.

  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . (1993). Cell, 75, 817–825.

  • Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF . (1996). Science, 271, 1744–1747.

  • Fukasawa K, Wiener F, Vande Woude GF and Mai S . (1997). Oncogene, 15, 1295–1302.

  • Garrett-Sinha LA, Eberspaecher H, Seldin MF and de Crombrugghe B . (1996). J. Biol. Chem., 271, 31384–31390.

  • Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C and Weinberg RA . (1996). Oncogene, 12, 1173–1180.

  • Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G and Ried T . (2000). Genes Chromosomes Cancer, 27, 183–190.

  • Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA . (1993). Oncogene, 8, 2457–2467.

  • Hinchcliffe EH, Li C, Thompson EA, Maller JL and Sluder G . (1999). Science, 283, 851–854.

  • Hinchcliffe EH and Sluder G . (2001). Genes Dev., 15, 1167–1181.

  • Hinchcliffe EH and Sluder G . (2002). Oncogene, 21, 6154–6160.

  • Hollstein M, Sidransky D, Vogelstein B and Harris CC . (1991). Science, 253, 49–53.

  • Joshi HC, Palacios MJ, McNamara L and Cleveland DW . (1992). Nature, 356, 80–83.

  • Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-Yamamoto K, Suzuki K and Fukasawa K . (2004). Cancer Res., 64, 4800–4809.

  • Kellogg DR . (1989). Nature, 340, 99–100.

  • Kirschner MW and Mitchison T . (1986). Nature, 324, 621.

  • Kuo KK, Sato N, Mizumoto K, Maehara N, Yonemasu H, Ker CG, Sheen PC and Tanaka M . (2000). Hepatology, 31, 59–64.

  • Lee JM, Abrahamson JL, Kandel R, Donehower LA and Bernstein A . (1994). Oncogene, 9, 3731–3736.

  • Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C and Salisbury JL . (2002). Proc. Natl. Acad. Sci. USA, 99, 1978–1983.

  • Lingle WL, Lutz WH, Ingle JN, Maihle NJ and Salisbury JL . (1998). Proc. Natl. Acad. Sci. USA, 95, 2950–2955.

  • Lingle WL and Salisbury JL . (1999). Am. J. Pathol., 155, 1941–1951.

  • Mantel C, Braun SE, Reid S, Henegariu O, Liu L, Hangoc G and Broxmeyer HE . (1999). Blood, 93, 1390–1398.

  • Mayer F, Stoop H, Sen S, Bokemeyer C, Oosterhuis JW and Looijenga LH . (2003). Oncogene, 22, 3859–3866.

  • Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA and Fukasawa K . (2000). Oncogene, 19, 1635–1646.

  • Ohtani K, DeGregori J and Nevins JR . (1995). Proc. Natl. Acad. Sci. USA, 92, 12146–12150.

  • Ouyang X, Wang X, Xu K, Jin DY, Cheung AL, Tsao SW and Wong YC . (2001). Biochim. Biophys. Acta, 1541, 212–220.

  • Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P and Doxsey SJ . (1998). Cancer Res., 58, 3974–3985.

  • Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L and Doxsey SJ . (2001). Cancer Res., 61, 2212–2219.

  • Pihan GA, Wallace J, Zhou Y and Doxsey SJ . (2003). Cancer Res., 63, 1398–1404.

  • Sato N, Mizumoto K, Nakamura M, Maehara N, Minamishima YA, Nishio S, Nagai E and Tanaka M . (2001). Cancer Genet. Cytogenet., 126, 13–19.

  • Sato N, Mizumoto K, Nakamura M, Nakamura K, Kusumoto M, Niiyama H, Ogawa T and Tanaka M . (1999). Clin. Cancer Res., 5, 963–970.

  • Schatten H, Wiedemeier AM, Taylor M, Lubahn DB, Greenberg NM, Besch-Williford C, Rosenfeld CS, Day JK and Ripple M . (2000). Biol. Cell, 92, 331–340.

  • Shields JM, Christy RJ and Yang VW . (1996). J. Biol. Chem., 271, 20009–20017.

  • Shields JM and Yang VW . (1997). J. Biol. Chem., 272, 18504–18507.

  • Sluder G, Thompson EA, Miller FJ, Hayes J and Rieder CL . (1997). J. Cell Sci., 110 (Part 4), 421–429.

  • Tarapore P and Fukasawa K . (2002). Oncogene, 21, 6234–6240.

  • Tarapore P, Okuda M and Fukasawa K . (2002). Cell Cycle, 1, 75–81.

  • Tokuyama Y, Horn HF, Kawamura K, Tarapore P and Fukasawa K . (2001). J. Biol. Chem., 276, 21529–21537.

  • Vogelstein B, Lane D and Levine AJ . (2000). Nature, 408, 307–310.

  • Waldman T, Kinzler KW and Vogelstein B . (1995). Cancer Res., 55, 5187–5190.

  • Weaver Z, Montagna C, Xu X, Howard T, Gadina M, Brodie SG, Deng CX and Ried T . (2002). Oncogene, 21, 5097–5107.

  • Weber RG, Bridger JM, Benner A, Weisenberger D, Ehemann V, Reifenberger G and Lichter P . (1998). Cytogenet. Cell Genet., 83, 266–269.

  • Yoon HS, Chen X and Yang VW . (2003). J. Biol. Chem., 278, 2101–2105.

  • Yoon HS and Yang VW . (2004). J. Biol. Chem., 279, 5035–5041.

  • Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS and Yang VW . (2000). J. Biol. Chem., 275, 18391–18398.

  • Zhang W, Shields JM, Sogawa K, Fujii-Kuriyama Y and Yang VW . (1998). J. Biol. Chem., 273, 17917–17925.

  • Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE and Yang VW . (2004). Oncogene, 23, 395–402.

Download references

Acknowledgements

We thank Dr B Vogelstein for providing the HCT116 p53+/+ and HCT116 p53−/− cell line and Dr R Weinberg for providing the cyclin E luciferase reporter plasmid. This work was in part supported by grants from the National Institutes of Health (DK52230, DK64399, and CA84197). VWY is the recipient of a Georgia Cancer Coalition Distinguished Cancer Clinician Scientist award. WBD is a recipient of a Medical Scientist Training Program grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincent W Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoon, H., Ghaleb, A., Nandan, M. et al. Krüppel-like factor 4 prevents centrosome amplification following γ-irradiation-induced DNA damage. Oncogene 24, 4017–4025 (2005). https://doi.org/10.1038/sj.onc.1208576

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208576

Keywords

This article is cited by

Search

Quick links